---

Andrew Lees

Scientific Director, Fina BioSolutions LLC

“My most significant contribution is the development of CDAP chemistry for conjugate vaccines,” says Andrew. “CDAP is perhaps the simplest and most efficient chemistry for making conjugate vaccines. It is used by GSK in their pneumonia and meningococcal vaccines and emerging market manufacturers are using CDAP chemistry to develop more affordable conjugate vaccines.”

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016